{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:41:02Z","timestamp":1790674862297,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.ab.2004.08.014","type":"journal-article","created":{"date-parts":[[2004,10,5]],"date-time":"2004-10-05T11:08:50Z","timestamp":1096974530000},"page":"81-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["Alzheimer\u2019s \u03b2-peptide oligomer formation at physiologic concentrations"],"prefix":"10.1016","volume":"335","author":[{"given":"Harry","family":"LeVine III","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ab.2004.08.014_bib1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1474-4422(03)00431-9","article-title":"Soluble amyloid oligomers: a common cause of neurodegeneration?","volume":"2","author":"Senior","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ab.2004.08.014_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0166-2236(00)01749-5","article-title":"Targeting small Abeta oligomers: the solution to an Alzheimer\u2019s disease conundrum?","volume":"24","author":"Klein","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ab.2004.08.014_bib3","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nn0901-887","article-title":"The \u2018Arctic\u2019 APP mutation (E693G) causes Alzheimer\u2019s disease by enhanced Abeta protofibril formation","volume":"4","author":"Nilsberth","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ab.2004.08.014_bib4","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1021\/bi030086j","article-title":"Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in parkinson\u2019s disease","volume":"42","author":"Volles","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2004.08.014_bib5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ab.2004.08.014_bib6","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","article-title":"Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline","volume":"283","author":"Naslund","year":"2000","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ab.2004.08.014_bib7","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","article-title":"Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease","volume":"60","author":"Giannakopoulos","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ab.2004.08.014_bib8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.61.3.378","article-title":"Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function","volume":"61","author":"Bennett","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ab.2004.08.014_bib9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00005072-199705000-00009","article-title":"The mean Abeta load in the hippocampus correlates with duration and severity of dementia in subgroups of Alzheimer disease","volume":"56","author":"Bartoo","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ab.2004.08.014_bib10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ab.2004.08.014_bib11","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ab.2004.08.014_bib12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7085","article-title":"The levels of soluble versus insoluble brain Abeta distinguish Alzheimer\u2019s disease from normal and pathologic aging","volume":"158","author":"Wang","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ab.2004.08.014_bib13","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M201750200","article-title":"Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability","volume":"277","author":"Dahlgren","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2004.08.014_bib14","doi-asserted-by":"crossref","first-page":"8876","DOI":"10.1523\/JNEUROSCI.19-20-08876.1999","article-title":"Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons","volume":"19","author":"Hartley","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ab.2004.08.014_bib15","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1074\/jbc.271.8.4077","article-title":"Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains","volume":"271","author":"Kuo","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2004.08.014_bib16","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.1834302100","article-title":"Alzheimer\u2019s disease-affected brain: presence of oligomeric Abeta ligands (ADDLs) suggests a molecular basis for reversible memory loss","volume":"100","author":"Gong","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ab.2004.08.014_bib17","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1073\/pnas.022662599","article-title":"Conformational Abs recognizing a generic amyloid fibril epitope","volume":"99","author":"O\u2019Nuallain","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ab.2004.08.014_bib18","doi-asserted-by":"crossref","first-page":"11682","DOI":"10.1021\/bi030100s","article-title":"Humoral immune response to fibrillar beta-amyloid peptide","volume":"42","author":"Miller","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2004.08.014_bib19","doi-asserted-by":"crossref","first-page":"12749","DOI":"10.1021\/bi030029q","article-title":"Self-assembly of Abeta(1-42) into globular neurotoxins","volume":"42","author":"Chromy","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2004.08.014_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0076-6879(99)09021-7","article-title":"Quantifying amyloid by congo red spectral shift assay","volume":"309","author":"Klunk","year":"1999","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ab.2004.08.014_bib21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","article-title":"Quantification of beta-sheet amyloid fibril structures with thioflavin T","volume":"309","author":"LeVine III","year":"1999","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ab.2004.08.014_bib22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0197-4580(95)00052-G","article-title":"Soluble multimeric Alzheimer beta(1-40) pre-amyloid complexes in dilute solution","volume":"16","author":"LeVine III","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ab.2004.08.014_bib23","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1073\/pnas.222681699","article-title":"Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways","volume":"100","author":"Bitan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ab.2004.08.014_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0006-8993(94)90688-2","article-title":"Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide","volume":"651","author":"Dudek","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.ab.2004.08.014_bib25","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1006\/bbrc.2000.3051","article-title":"Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer\u2019s disease","volume":"273","author":"El Agnaf","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ab.2004.08.014_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-5793(97)01290-8","article-title":"Hemin and related porphyrins inhibit beta-amyloid aggregation","volume":"417","author":"Howlett","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ab.2004.08.014_bib27","first-page":"1137","article-title":"Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide","volume":"15","author":"Ward","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.ab.2004.08.014_bib28","doi-asserted-by":"crossref","first-page":"13489","DOI":"10.1021\/bi020369w","article-title":"Kinetic modeling and determination of reaction constants of Alzheimer\u2019s beta-amyloid fibril extension and dissociation using surface plasmon resonance","volume":"41","author":"Hasegawa","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2004.08.014_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-1759(99)00166-0","article-title":"A stable and highly sensitive 3,3\u2032,5,5\u2032-tetramethylbenzidine-based substrate reagent for enzyme-linked immunosorbent assays","volume":"233","author":"Frey","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ab.2004.08.014_bib30","doi-asserted-by":"crossref","first-page":"35176","DOI":"10.1074\/jbc.M102223200","article-title":"Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins","volume":"276","author":"Bitan","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2004.08.014_bib31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archneur.57.1.100","article-title":"Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease","volume":"57","author":"Mehta","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ab.2004.08.014_bib32","doi-asserted-by":"crossref","first-page":"12277","DOI":"10.1073\/pnas.95.21.12277","article-title":"Temperature dependence of amyloid beta-protein fibrillization","volume":"95","author":"Kusumoto","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ab.2004.08.014_bib33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/jsbi.2000.4276","article-title":"Activation barriers to structural transition determine deposition rates of Alzheimer\u2019s disease a beta amyloid","volume":"130","author":"Esler","year":"2000","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ab.2004.08.014_bib34","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1073\/pnas.93.3.1125","article-title":"On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants","volume":"93","author":"Lomakin","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ab.2004.08.014_bib35","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","article-title":"The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer\u2019s disease","volume":"32","author":"Jarrett","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2004.08.014_bib36","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0006-3495(84)84062-X","article-title":"Kinetics of nucleation-controlled polymerization. A perturbation treatment for use with a secondary pathway","volume":"46","author":"Bishop","year":"1984","journal-title":"Biophys. J."},{"key":"10.1016\/j.ab.2004.08.014_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0022-2836(02)01175-0","article-title":"Assembly of amyloid protofibrils via critical oligomers\u2014a novel pathway of amyloid formation","volume":"325","author":"Modler","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ab.2004.08.014_bib38","doi-asserted-by":"crossref","first-page":"10424","DOI":"10.1021\/bi990718v","article-title":"Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer\u2019s disease amyloid plaques in human brain preparations","volume":"38","author":"Tseng","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2004.08.014_bib39","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1006\/jmbi.2001.4970","article-title":"Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis","volume":"312","author":"Kirkitadze","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ab.2004.08.014_bib40","unstructured":"N. Bark, L. Tjernberg, R. Rigler, L. Terenius, Fluorescence Burst Analysis of Cerebrospinal Fluid as a Diagnostic Tool for Alzheimer\u2019s Disease, 8th International Conference on Alzheimers Disease and Related Disorders (2002) (Abstr 1382)"},{"key":"10.1016\/j.ab.2004.08.014_bib41","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/nm0798-832","article-title":"Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer\u2019s patients by fluorescence correlation spectroscopy","volume":"4","author":"Pitschke","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.ab.2004.08.014_bib42","doi-asserted-by":"crossref","first-page":"25949","DOI":"10.1074\/jbc.274.36.25945","article-title":"Amyloid \u03b2-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates","volume":"274","author":"Walsh","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2004.08.014_bib43","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ab.2004.08.014_bib44","doi-asserted-by":"crossref","first-page":"22364","DOI":"10.1074\/jbc.272.35.22364","article-title":"Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate","volume":"272","author":"Walsh","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2004.08.014_bib45","doi-asserted-by":"crossref","first-page":"21037","DOI":"10.1074\/jbc.272.34.21037","article-title":"Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations","volume":"272","author":"Garzon-Rodriguez","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2004.08.014_bib46","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0022-2836(03)00927-6","article-title":"Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 in vitro accumulate protofibrils, including amyloid pores","volume":"332","author":"Lashuel","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ab.2004.08.014_bib47","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1074-5521(00)00020-X","article-title":"Scope, limitations and mechanistic aspects of the photo-induced cross-linking of proteins by water-soluble metal complexes","volume":"7","author":"Fancy","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ab.2004.08.014_bib48","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1073\/pnas.96.11.6020","article-title":"Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light","volume":"96","author":"Fancy","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ab.2004.08.014_bib49","series-title":"Principles of Polymer Chemistry","author":"Flory","year":"1953"},{"key":"10.1016\/j.ab.2004.08.014_bib50","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1039\/B308788C","article-title":"Nucleation-elongation: a mechanism for cooperative supramolecular polymerization","volume":"1","author":"Zhao","year":"2003","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ab.2004.08.014_bib51","doi-asserted-by":"crossref","first-page":"16294","DOI":"10.1021\/ja038252y","article-title":"Nucleation\u2013elongation polymerization under imbalanced stoichiometry","volume":"125","author":"Zhao","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ab.2004.08.014_bib52","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0304-3940(01)01754-2","article-title":"Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease","volume":"304","author":"Mehta","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ab.2004.08.014_bib53","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1749-6632.2000.tb06357.x","article-title":"Traumatic brain injury elevates the Alzheimer\u2019s amyloid peptide Abeta 42 in human CSF. A possible role for nerve cell injury","volume":"903","author":"Emmerling","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ab.2004.08.014_bib54","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/01.WNL.0000091890.32140.8F","article-title":"Plasma Abeta40 and Abeta42 and Alzheimer\u2019s disease: relation to age, mortality, and risk","volume":"61","author":"Mayeux","year":"2003","journal-title":"Neurology"}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269704006645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269704006645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T20:37:06Z","timestamp":1757709426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269704006645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0003269704006645"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2004.08.014","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alzheimer\u2019s \u03b2-peptide oligomer formation at physiologic concentrations","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2004.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}